Prospective phase II study of R-CHOP chemotherapy in combination with intensive CNS prophylaxis in patients with Diffused Large B-Cell Lymphoma of the testis (DLBCL) - Code IELSG 30 - EudraCT Number 2009-011789-26
Project Objectives
Phase II study in which all recruited patients undergo chemo-immunotherapy (R-CHOP) associated with the intrathecal infusion of liposomal cytarabine.
Start/End Date
February 17, 2009 - ongoing
Principal Investigator
Prof. Giuseppe Avvisati
Host Institution
IELSG - International Extranodal Lymphoma Study Group
Source of funding
IELSG - International Extranodal Lymphoma Study Group
Project objectivesStudio di fase II in cui tutti i pazienti reclutati vengono sottoposti a chemio-immunoterapia (R-CHOP) associata all’infusione intratecale della citarabina liposomiale. |
Start and end date |
17/02/2009 - ongoing |
Project Manager |
Prof. Giuseppe Avvisati |
Coordinating institution of the project |
IELSG - International Extranodal Lymphoma Study Group |
Funding source(s). |
IELSG - International Extranodal Lymphoma Study Group |